These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 16585173)
1. Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression. Huh JI; Calvo A; Charles R; Green JE Cancer Res; 2006 Apr; 66(7):3495-503. PubMed ID: 16585173 [TBL] [Abstract][Full Text] [Related]
2. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379 [TBL] [Abstract][Full Text] [Related]
3. 2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo. Cicek M; Iwaniec UT; Goblirsch MJ; Vrabel A; Ruan M; Clohisy DR; Turner RR; Oursler MJ Cancer Res; 2007 Nov; 67(21):10106-11. PubMed ID: 17974950 [TBL] [Abstract][Full Text] [Related]
4. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874 [TBL] [Abstract][Full Text] [Related]
5. 2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice. Huh JI; Qiu TH; Chandramouli GV; Charles R; Wiench M; Hager GL; Catena R; Calvo A; LaVallee TM; Desprez PY; Green JE Endocrinology; 2007 Mar; 148(3):1266-77. PubMed ID: 17158205 [TBL] [Abstract][Full Text] [Related]
6. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression. Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389 [TBL] [Abstract][Full Text] [Related]
7. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells. Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013 [TBL] [Abstract][Full Text] [Related]
8. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262 [TBL] [Abstract][Full Text] [Related]
9. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069. Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861 [TBL] [Abstract][Full Text] [Related]
10. Evidence that 2-methoxyestradiol suppresses proliferation and accelerates apoptosis in normal rat growth plate chondrocytes. Sibonga JD; Sommer U; Turner RT J Cancer Res Clin Oncol; 2002 Sep; 128(9):477-83. PubMed ID: 12242511 [TBL] [Abstract][Full Text] [Related]
11. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors. Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038 [TBL] [Abstract][Full Text] [Related]
12. 2-methoxyestradiol induces morpho-functional changes and impairs the microtubular system in mouse neuroblastoma and rat glioma cells. Manca P; Chisu V Arch Ital Biol; 2010 Mar; 148(1):11-21. PubMed ID: 20426250 [TBL] [Abstract][Full Text] [Related]
13. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756 [TBL] [Abstract][Full Text] [Related]
14. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice. Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE Oncogene; 2001 Apr; 20(16):2044-9. PubMed ID: 11360188 [TBL] [Abstract][Full Text] [Related]
15. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats. Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706 [TBL] [Abstract][Full Text] [Related]
16. [Inhibitive effects of mifepristone on growth of breast cancer: experiment with animal model]. Tian XS; Zhou WH; Wu GJ; Sun JZ; Cong MH Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):559-63. PubMed ID: 18649774 [TBL] [Abstract][Full Text] [Related]
17. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of breast cancer-additive anticancerogenic effects by 2-methoxyestradiol? Mueck AO; Seeger H; Huober J Life Sci; 2004 Jul; 75(10):1205-10. PubMed ID: 15219808 [TBL] [Abstract][Full Text] [Related]
19. In vitro effects of 2-methoxyestradiol on MCF-12A and MCF-7 cell growth, morphology and mitotic spindle formation. Van Zijl C; Lottering ML; Steffens F; Joubert A Cell Biochem Funct; 2008; 26(5):632-42. PubMed ID: 18508385 [TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells? Azab SS; Salama SA; Abdel-Naim AB; Khalifa AE; El-Demerdash E; Al-Hendy A Breast Cancer Res Treat; 2009 Jan; 113(1):9-19. PubMed ID: 18228136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]